{Reference Type}: Letter
{Title}: The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. "Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies".
{Author}: Jones G;Machado-Vieira R;
{Journal}: Mol Psychiatry
{Volume}: 28
{Issue}: 8
{Year}: 2023 Aug 12
{Factor}: 13.437
{DOI}: 10.1038/s41380-023-02102-2